CD8A and neoplasm: Tumor cells can be recognized and directly killed by activated CD8+ or CD4+ T cells after the tumor antigens are processed and presented by antigen-presenting cells (APCs) through major histocompatibility complex class I (MHC class I) or class II (MHC class II) molecules (18, 19).